NIH-funded research NIH-funded research

A handheld camera for screening eye diseases in newborns

Official title: RetiVue EntireEye - A Handheld, High-Resolution, Non-Contact, One Image, Widefield Retinal Screening Camera for Premature and Healthy Newborn Babies

Funded at Retivue · NIH-11068765 · Data updated 2026-11-12

This study is working on a new, easy-to-use camera that takes clear pictures of the eyes of premature babies to help doctors quickly check for vision problems, making it simpler to get the care these little ones need.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionRetivue
NIH-funded
Lab location1 site (Charlottesville, United States)
Project startMay 1, 2025
Project endApril 30, 2026
Funding year2025
Award (this year)$745,607
NIH project number1SB1EY037120-01
Project IDNIH-11068765 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are premature newborns, particularly those under 4 weeks old, who are at risk for retinopathy of prematurity.

Less likely to help

Patients who are not newborns or those who do not have risk factors for retinopathy of prematurity may not benefit from this research.

What this research studies

This research focuses on developing a portable, high-resolution camera designed to screen for retinopathy of prematurity (ROP) in newborn babies. The camera captures detailed images of the retina in a single shot, making it easier and more efficient to diagnose potential vision problems. By utilizing advanced imaging technology and artificial intelligence, the device aims to provide high-quality diagnostic images that can be used for telemedicine applications, ensuring timely screening for all infants. This approach addresses the shortage of trained ophthalmologists and the limitations of current screening methods.

Why it matters

Potential benefit: If successful, this research could significantly improve early detection and treatment of eye diseases in premature infants, potentially preventing blindness.

How similar studies have gone: Previous research has shown success with telemedicine approaches in screening for eye diseases, indicating that this novel technology could also be effective.

Where this research is happening

  • Retivue
    Charlottesville, United States
    Active

Researchers

  • Principal investigator: Yates, Paul a. — Retivue
  • Study coordinator: Yates, Paul a.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.